Omada Health vs Moderna
Side-by-side comparison of AI visibility scores, market position, and capabilities
Omada Health is a virtual-first chronic care platform for diabetes, hypertension, and musculoskeletal conditions serving 2,000+ employer and health plan customers, with $170M 2024 revenue and a June 2025 Nasdaq IPO (OMDA).
About
Omada Health is a San Francisco-based digital health company founded in 2012 that offers virtual-first care programs for chronic conditions including prediabetes, Type 1 and Type 2 diabetes, hypertension, and musculoskeletal disorders. The platform combines human health coaches, licensed clinical practitioners, and connected devices—including cellular-enabled scales and continuous glucose monitors—with behavior science and clinical protocols to deliver personalized, data-driven care at scale. Omada describes its approach as "Compassionate Intelligence," integrating human relationships with AI-driven personalization.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
About
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.